Trump’s FDA pick to face scrutiny over abortion pill access at confirmation hearing

Key Points:

• Dr. Heidi Overton, an opponent of abortion rights, is scheduled for a Senate confirmation hearing to lead the FDA amid Republican pressure to tighten access to the abortion pill mifepristone, with Sen. Bill Cassidy playing a key role in the process.
• Cassidy has criticized mifepristone manufacturers for safety compliance issues and pushed for reversing Biden-era rules allowing telemedicine prescriptions and mail delivery of the pill; the FDA has launched a new safety study on mifepristone.
• Overton’s background includes work at a conservative think tank supporting restrictions on medication abortion and alignment with Health Secretary Robert F. Kennedy Jr.’s vaccine policies, though experts question her qualifications in clinical trials and agency management.
• Senators are expected to question Overton on her vaccine views, particularly regarding former President Trump’s false claim that the measles vaccine is lethal, with some critics suggesting her appointment is politically motivated rather than based on expertise.
• If confirmed, Overton will face challenges including managing food safety issues highlighted by recent large-scale foodborne illness outbreaks and restoring public trust in the FDA’s science-based and transparent decision-making.